FDA approves preventive migraine treatment

The Food and Drug Administration approved the first treatment for migraines in adults.

Posted: May 18, 2018 2:45 PM
Updated: May 18, 2018 2:47 PM

By Jacqueline Howard, CNN
(CNN) -- Migraine sufferers across the United States have their eyes on a newly approved drug that's offering hope for reducing the frequency of monthly migraine attacks.

On Thursday, the US Food and Drug Administration approved Aimovig for the preventive treatment of migraines in adults with episodic or chronic migraines. Episodic migraine is when symptoms occur zero to 14 days each month; symptoms of chronic migraine occur 15 days or more a month.

Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, or CGRP, a molecule that is involved in migraine attacks. Aimovig targets that molecule's receptor in your body.

The treatment, administered through monthly self-injections, requires a prescription and could be available to patients within a week. Aimovig is expected to cost $575 monthly or $6,900 annually in the United States.

There are three other migraine treatments in this newly emerging class of drugs.

Those drugs target the CGRP molecule itself, instead of its receptor. They are experimental but, if approved, might be made available to patients as early as this fall for one and next year for the others, said Dr. Stewart Tepper, director of the Dartmouth Headache Center at Dartmouth-Hitchcock Medical Center in New Hampshire, who was a clinical investigator in the Aimovig trials.

"When CGRP is released, outside of the brain, it causes inflammation and blood vessel dilation -- the blood vessels get big -- and that combination of inflammation and blood vessels getting big is the pain of migraine," said Tepper, who is also a professor of neurology at the Geisel School of Medicine at Dartmouth College.

Migraine is three times more common in women than in men and affects more than 10% of people worldwide, the FDA noted. In the US, about 12% of the population gets migraine headaches.

What was found in clinical trials
The effectiveness of Aimovig was evaluated in three key clinical trials.

The first included 955 people with a history of episodic migraine. Over the course of six months, those who received the treatment experienced one or two fewer monthly migraine days, on average, compared with a placebo.

The second study included 577 patients with a history of episodic migraine. Over the course of three months, those who received Aimovig treatment experienced one fewer migraine day per month.

The third study evaluated 667 patients with a history of chronic migraine. Over the course of three months, patients treated with Aimovig experienced, on average, 2½ fewer monthly migraine days than those receiving a placebo.

"It may not get rid of all of them, but it really dramatically improves the frequency, severity and duration of the migraine attacks," Tepper said of the new treatment.

Patients "still will need to take something when they get a migraine attack, but this is the first designer medication to prevent migraine rather than treat as needed," he said.

In the clinical studies, the most common adverse side effects were pain at the injection site and constipation. The drug can be injected in the thigh, the abdomen or the outer area of the upper arm.

"The field is excited about a new drug that is specifically targeted for migraine mechanisms," said Dr. Teshamae Monteith, assistant professor of clinical neurology at the University of Miami and a member of the American Academy of Neurology, who was not involved in the development of the drug.

"Not only does the data show that it's effective for people who have what we call episodic migraine, but it's also effective for people who have chronic migraine," Monteith said.

"If you can imagine, a patient with chronic migraine has at least 15 days -- half the month -- with some type of headache, and eight days out of that month, it's what you would call a moderate to severe headache with associated symptoms, such as light sensitivity, sound sensitivity, some cognitive dysfunction, [gastrointestinal] symptoms and sometimes visual and motor symptoms," she said. "Patients can have fatigue, concentration impairment, neck stiffness and sometimes mood changes as well."

By Friday, Monteith was already receiving requests for prescriptions and questions about Aimovig from her patients, including Helene Good, who uses injections of Botox to treat her migraines.

'It's really exciting'
"I first heard about it when it showed up on my phone this morning as an article in my news, and I just happened to be on my way to see Dr. Monteith for my treatment today," Good said Friday.

"I read it to my spouse on the way over, and it's really exciting," said Good, a 63-year-old Miami resident who has had migraines since she was in her late teens.

"It's not like just having a bad headache. For me, it manifests in other ways," she said. "One side of my face droops, which sort of looks like I've had a mini stroke. I'm a pretty fast speaker, but my speech gets very slow."

When it comes to migraine treatment options, "you're always hoping and looking for hope," she said.

Treatment options for migraine sufferers typically depend on the frequency and severity of the migraine attacks. Patients who have episodic migraine usually rely on pain medications to treat the migraine pain. To avoid episodes, some patients may stay away from triggers, such as certain foods, lack of sleep or stress.

Before Aimovig, "the FDA-approved preventive medications for episodic migraine were only four. Two of them are beta blockers, anti-blood pressure medicines, and two of them are anti-epilepsy drugs," Tepper said.

"There was one FDA-approved treatment for chronic migraine, which was Botox," he said. For patients, "with our current preventive medicines, they have to take oral medicine every day, with the exception of Botox, which is given in 31 injections every 12 weeks."

Yet a problem with many of those other treatment options is that some are traditionally used for other disorders and have side effects, Monteith said.

"Not only are some of the drugs not effective for every patient, but then there's this issue with tolerability," she said. "Some of these drugs are not well-tolerated. In the right person, it's great, but certainly we need some other option."

Additionally, there are medical devices such as a FDA-approved nerve-stimulating "tiara" called Cefaly, another nerve-stimulating device called gammaCore and even an approach called transcranial magnetic stimulation. Some patients have turned to acupuncture for migraine therapy.

"As a headache specialist, there are a number of treatments that are available for our patients preventively for migraine, but many of them are associated with a lot of different side effects, and we've been waiting for the day when we can have a medication that specifically targets migraine and prevents it in this unique modality and is associated with few side effects," said Dr. Thomas Berk, headache neurologist at NYU Langone Health, who was not involved in the development of the new treatment.

"I've had a number of requests already from patients asking, is it possible to get it to them quickly? What are the ways of getting it, and the big question being, is my insurance going to cover it, which is a question that we don't really know particularly yet," he said. "Everyone's excited about it."

The-CNN-Wire
™ & © 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved.

Huntsville/Redstone
Cloudy
44° wxIcon
Hi: 57° Lo: 41°
Feels Like: 39°
Muscle Shoals
Cloudy
45° wxIcon
Hi: 56° Lo: 38°
Feels Like: 40°
Huntsville/Madison
Cloudy
43° wxIcon
Hi: 54° Lo: 40°
Feels Like: 37°
Decatur
Cloudy
43° wxIcon
Hi: 58° Lo: 42°
Feels Like: 37°
Fort Payne
Cloudy
43° wxIcon
Hi: 57° Lo: 39°
Feels Like: 36°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Cases: 498076

Reported Deaths: 10094
CountyCasesDeaths
Jefferson716711387
Mobile36294737
Madison32616468
Tuscaloosa24340421
Montgomery22739519
Shelby22174218
Baldwin19873289
Lee15039157
Calhoun13832293
Morgan13753254
Etowah13390325
Marshall11448211
Houston10124264
Elmore9483190
Limestone9420138
St. Clair9022227
Cullman8984182
Lauderdale8612214
DeKalb8489175
Talladega7606165
Walker6585259
Jackson6545104
Autauga632492
Blount6236127
Colbert6001121
Coffee5264103
Dale4671107
Russell406933
Franklin399878
Covington3993106
Chilton3898103
Escambia379173
Tallapoosa3622143
Clarke344053
Chambers3431111
Dallas3422142
Pike293373
Marion288695
Lawrence284985
Winston258368
Bibb246160
Geneva240370
Marengo238857
Pickens225457
Barbour213651
Hale212269
Fayette202057
Butler201466
Henry183541
Cherokee178039
Monroe166739
Randolph164840
Washington156836
Macon147745
Crenshaw146255
Clay145954
Cleburne139841
Lamar133733
Lowndes132751
Wilcox122925
Bullock117336
Conecuh107024
Perry106127
Sumter99732
Coosa90224
Greene88532
Choctaw55323
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 779449

Reported Deaths: 11501
CountyCasesDeaths
Shelby876181509
Davidson81809871
Knox46250587
Hamilton40539463
Rutherford38563386
Williamson25382204
Sumner21448318
Montgomery17484213
Out of TN1706694
Wilson16510211
Unassigned15772127
Sullivan14431274
Blount14141183
Bradley12996141
Washington12818234
Maury12246163
Sevier12109164
Putnam10635170
Madison10123230
Robertson8997121
Hamblen8063165
Anderson8044158
Greene7309145
Tipton6962103
Coffee6418115
Dickson6256106
Gibson6196141
Cumberland6127122
Carter5990155
McMinn594592
Roane592696
Bedford5816120
Loudon571966
Jefferson5688119
Lawrence557483
Monroe536590
Warren532576
Hawkins527195
Dyer5242101
Franklin475785
Fayette468372
Obion436995
Lincoln415662
Rhea415273
Cocke401295
Cheatham394544
Marshall391956
Campbell381859
Weakley379359
Giles375297
Henderson362273
Carroll349181
White339366
Hardeman338864
Macon337273
Hardin331563
Lauderdale309642
Henry301275
Marion294744
Scott288144
Wayne287630
Overton285557
Claiborne283069
McNairy268353
Hickman266541
DeKalb266151
Haywood264960
Smith256936
Grainger244246
Trousdale239822
Morgan230338
Fentress229544
Johnson217138
Chester202348
Bledsoe201010
Crockett197547
Unicoi181447
Polk177722
Cannon176730
Union173033
Grundy169730
Lake167926
Sequatchie157327
Humphreys154921
Decatur153837
Benton151039
Lewis147425
Meigs126722
Jackson125634
Stewart124025
Clay107130
Houston103632
Perry103527
Moore94516
Van Buren79720
Pickett74623
Hancock49712

Community Events